Microbot Medical
MBOT
22 hedge funds and large institutions have $265K invested in Microbot Medical in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 16 closing their positions.
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
35% less funds holding
Funds holding: 34 → 22 (-12)
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
91% less capital invested
Capital invested by funds: $3.11M → $265K (-$2.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$154K |
| 2 |
Renaissance Technologies
New York
|
+$110K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$44.1K |
| 4 |
Goldman Sachs
New York
|
+$32.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$854K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$303K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$182K |
| 4 |
Bank of New York Mellon
New York
|
-$29K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$21K |
MBOT Hedge Fund Activity: Q2 2016 in Review
22 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2016, worth a combined $265K — down 91% from $3.11M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of MBOT and 4 opened new positions — a net loss of 12 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Virtu KCG Holdings, adding an estimated $154K. The largest seller was Anson Funds Management, exiting entirely with an estimated $854K sold.
- 22 institutional investors held Microbot Medical (MBOT) as of Q2 2016, down from 34 in Q1 2016.
- Funds reported $265K of Microbot Medical stock for Q2 2016, down 91% quarter-over-quarter.
- 4 funds opened new Microbot Medical positions in Q2 2016 and 16 closed out, a net change of -12 holders.
- The largest Microbot Medical buyer in Q2 2016 was Virtu KCG Holdings, an estimated $154K added.
- The largest Microbot Medical seller in Q2 2016 was Anson Funds Management, an estimated $854K sold.
Based on aggregated 13F filings for Q2 2016.